|
Tabla 2: Riesgos proporcionales de Cox para variables asociadas. |
|||
|
Variable |
HR |
p |
IC |
|
Edad |
1.06 |
0.000 |
1.030-1.105 |
|
Uso de corticosteroides |
2.20 |
0.454 |
0.279-17.358 |
|
Uso de tocilizumab |
0.54 |
0.159 |
0.229-1.273 |
|
SOFA |
2.31 |
0.039 |
1.043-5.152 |
|
APACHE II |
1.10 |
0.864 |
0.339-3.610 |
|
SAPS II |
0.94 |
0.939 |
0.247-3.646 |
|
Diabetes mellitus |
2.47 |
0.019 |
1.163-5.264 |
|
EPOC |
1.35 |
0.632 |
0.392-4.672 |
|
Cáncer |
0.41 |
0.262 |
0.092-1.914 |
|
Cardiopatía isquémica |
3.29 |
0.069 |
0.944-11.505 |
|
Fibrilación atrial |
0.57 |
0.546 |
0.094-3.481 |
|
pH |
0.04 |
0.069 |
0.001-1.265 |
|
Dímero D |
1.00 |
0.320 |
0.999-1.000 |
|
HR = Hazard Ratio, IC = intervalo de confianza, SOFA = Sequential Organ Failure Assessment, APACHE II = Acute Physiology Age Chronic Health Evaluation, SAPS II = Simplified Acute Physiology score II, EPOC = enfermedad pulmonar obstructiva crónica. |
|||